Human obesity and insulin resistance: Lessons from experiments of nature

Novartis Foundation Symposium

Volumn 286, Issue , 2007, Pages 13-20

  O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN;

ADIPOCYTE; ARTICLE; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY;

ADIPOCYTES; ADIPONECTIN; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; LEPTIN; OBESITY;

EID: 42449112574     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (38)

1. Agarwal AK, Garg A 2002 A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87:408-411
2. Agarwal AK, Garg A 2006 Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 57:297-311
3. Agostini M, Schoenmakers E, Mitchell C et al 2006 Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab 4:303-311
4. Alharbi KK, Spanakis E, Tan K et al 2007 Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Hum Mutat 28:294-302
5. Barroso I, Gurnell M, Crowley VE et al 1999 Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883
6. Challis BG, Pritchard LE, Creemers JW et al 2002 A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:1997-2004
7. Clement K, Vaisse C, Lahlou N et al 1998 A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401
8. Danforth E Jr 2000 Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13
9. Dib K, Whitehead JP, Humphreys PJ et al 1998 Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. J Clin Invest 101:1111-1120
10. Farooqi S, O'Rahilly S 2006 Genetics of obesity in humans. Endocr Rev 27:710-718
11. Farooqi IS, Jebb SA, Langmack G et al 1999 Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-84
12. Farooqi IS, Yeo GS, Keogh JM et al 2000 Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279
13. Farooqi IS, Matarese G, Lord GM et al 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-103
14. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095
15. Farooqi IS, Wangensteen T, Collins S et al 2007 Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356:237-247
16. Flier JS, Moller DE, Moses AC et al 1993 Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 76:1533-1541
17. George S, Rochford JJ, Wolfrum C et al 2004 A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304:1325-1328
18. Gibson WT, Farooqi IS, Moreau M et al 2004 Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 89:4821-4826
19. Gray J, Yeo GS, Cox JJ et al 2006a Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55:3366-3371
20. Gray SL, Nora ED, Grosse J et al 2006a Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55:2669-2677
21. Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T 2002 PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51:3586-3590
22. Jackson RS, Creemers JW, Ohagi S et al 1997 Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16:303-306
23. Jackson RS, Creemers JW, Farooqi IS et al 2003 Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560
24. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792
25. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O 2005 Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 90:219-224
26. Lee YS, Challis BG, Thompson DA et al 2006 A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 3:135-140
27. Licinio J, Caglayan S, Ozata M et al 2004 Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 101:4531-4536
28. Montague CT, Farooqi IS, Whitehead JP et al 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908
29. Musso C, Cochran E, Moran SA et al 2004 Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore) 83:209-222
30. Savage DB, Agostini M, Barroso I et al 2002 Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 31:379-384 (erratum: 2002 Nat Genet 32:211)
31. Savage DB, Tan GD, Acerini CL et al 2003 Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52:910-917
32. Semple RK, O'Rahilly S 2005 PPAR gamma and glucose homeostasis. In: Kumar S, O'Rahilly S (eds) Insulin resistance: insulin action and its disturbances in disease. Wiley, Chichester, p 237-267
33. Semple RK, Soos MA, Luan J et al 2006 Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219-23
34. Semple RK, Halberg NH, Burling K et al 2007 Paradoxical elevation of high molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712-1717
35. Trujillo ME, Scherer PE 2005 Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175
36. Tsai YS, Kim HJ, Takahashi N et al 2004 Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest 114:240-249
37. Xu B, Goulding EH, Zang K et al 2003 Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736-742
38. Yeo GS, Connie Hung CC, Rochford J et al 2004 A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 7:1187-1189